NCT01005654 2026-03-13Prospective Comprehensive Molecular Analysis of Endocrine NeoplasmsNational Institutes of Health Clinical Center (CC)Recruiting2,415 enrolled
NCT03420963 2026-03-03Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsM.D. Anderson Cancer CenterPhase 1 Terminated12 enrolled
NCT03899792 2026-01-06LIBRETTO-121Eli Lilly and CompanyPhase 1/2 Active not recruiting36 enrolled 13 charts 2 FDA